Related Experiment Video
Updated: May 13, 2026

Modeling Neural Immune Signaling of Episodic and Chronic Migraine Using Spreading Depression In Vitro
Published on: June 13, 2011
Spreading depression triggers headache by activating neuronal Panx1 channels
Hulya Karatas1, Sefik Evren Erdener, Yasemin Gursoy-Ozdemir
1Institute of Neurological Sciences and Psychiatry, Hacettepe University, Ankara, Turkey.
A newly discovered pathway links stressed neurons to migraine pain via cortical spreading depression (CSD). Blocking this neuronal Pannexin1 (Panx1) cascade reduces CSD-induced migraine activation and headache.
Area of Science:
- Neuroscience
- Cellular Biology
- Pain Research
Background:
- The initial mechanisms driving migraine development remain unclear.
- Cortical spreading depression (CSD) is implicated in migraine aura and headache.
- Understanding neuronal signaling during CSD is crucial for migraine research.
Purpose of the Study:
- To elucidate a novel signaling pathway involved in the early stages of migraine.
- To investigate the role of neuronal Pannexin1 (Panx1) and downstream effectors in CSD.
- To determine if inhibiting this pathway can prevent CSD-induced migraine pathophysiology.
Main Methods:
- Induction of CSD in a relevant model.
- Measurement of Panx1 megachannel opening and caspase-1 activation.
- Analysis of high-mobility group box 1 (HMGB1) release and nuclear factor κB (NF-κB) activation.
- Assessment of trigeminovascular activation, mast cell degranulation, and headache behavior.
Main Results:
- CSD triggered Panx1 megachannel opening and caspase-1 activation in neurons.
- This led to HMGB1 release and subsequent NF-κB activation in astrocytes.
- Inhibition of this cascade successfully abolished CSD-induced trigeminovascular activation, mast cell degranulation, and headache.
- CSD-induced neuronal megachannel opening appears to sustain trigeminal afferent activation through glial inflammatory pathways.
Conclusions:
- A previously unknown signaling pathway involving Panx1, caspase-1, and HMGB1 mediates CSD-induced trigeminovascular activation.
- This pathway links neuronal stress to glial activation and trigeminal nerve sensitization, contributing to headache.
- Targeting this pathway offers a potential therapeutic strategy for migraine prevention.
Related Concept Videos
Depression: Overview
Panic Disorder
G-protein Coupled Receptors
Encephalitis ll: Pathophysiology
Depressive Disorders: Etiology
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

